Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Tumor-Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02022800
What this trial is testing

Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)

Who this might be right for
GliomaCerebral Metastases
Centre Antoine Lacassagne 85
Testing effectiveness (Phase 2)UnknownNCT00983398
What this trial is testing

Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

Who this might be right for
Central Nervous System Embryonal NeoplasmEmbryonal Tumor With Multilayered Rosettes, C19MC-AlteredGerm Cell Tumor+7 more
OHSU Knight Cancer Institute 17
Very early researchEnded earlyNCT04712721
What this trial is testing

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Who this might be right for
Glioblastoma MultiformeBrain NeoplasmsGastroesophageal Adenocarcinoma+1 more
Novartis Pharmaceuticals 14
Early research (Phase 1)Study completedNCT01172964
What this trial is testing

A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaRecurrent Grade III GliomaRecurrent Grade IV Glioma+9 more
City of Hope Medical Center 15
Not applicableStudy completedNCT04734444
What this trial is testing

SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue

Who this might be right for
Brain TumourHigh Grade GliomaLow-grade Glioma+1 more
SonoClear AS 45
Large-scale testing (Phase 3)Study completedNCT00820963
What this trial is testing

Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Centre Leon Berard 70
Not applicableNot Yet RecruitingNCT07813741
What this trial is testing

Susceptibility-Weighted Imaging in Preoperative Grading of Cerebral Gliomas

Who this might be right for
GliomaBrain NeoplasmsCerebral Glioma
Assiut University 90
Early research (Phase 1)Study completedNCT04019002
What this trial is testing

Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma

Who this might be right for
Glioblastoma Multiforme (GBM)
Susan Chang 17
Not applicableLooking for participantsNCT06896331
What this trial is testing

Inside a Neuron - Ex Vivo Evaluation of Cerebral and Cerebellar Neuronal Activity.

Who this might be right for
Human Neural Cells Functioning
Fondazione IRCCS Policlinico San Matteo di Pavia 60
Testing effectiveness (Phase 2)Study completedNCT01067469
What this trial is testing

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma
M.D. Anderson Cancer Center 83
Testing effectiveness (Phase 2)Looking for participantsNCT07416188
What this trial is testing

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeRelapsed Cancer+12 more
National Institute of Neurological Disorders and Stroke (NINDS) 40
Not applicableStudy completedNCT00006342
What this trial is testing

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
Duke University 19
Testing effectiveness (Phase 2)Study completedNCT00782756
What this trial is testing

Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Brain CancerMalignant Glioma
Memorial Sloan Kettering Cancer Center 40
Early research (Phase 1)Study completedNCT00002753
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT00602667
What this trial is testing

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 293
Testing effectiveness (Phase 2)Study completedNCT00433381
What this trial is testing

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult GlioblastomaAdult GliosarcomaRecurrent Adult Brain Neoplasm
National Cancer Institute (NCI) 123
Testing effectiveness (Phase 2)Ended earlyNCT03382977
What this trial is testing

Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

Who this might be right for
Glioblastoma Multiforme
VBI Vaccines Inc. 70
Very early researchWithdrawnNCT05054400
What this trial is testing

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

Who this might be right for
Brain MetastasesCancerGliomas+1 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07243470
What this trial is testing

Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors

Who this might be right for
GliomaCNS Tumor, AdultCNS Tumor, Childhood
Centre Leon Berard 70
Testing effectiveness (Phase 2)Ended earlyNCT00636805
What this trial is testing

Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab

Who this might be right for
Brain Cancer
Duke University 63
Next Page